Lifeward

Lifeward FCF/Debt

The Free Cash Flow to Debt Ratio of Lifeward (LFWD) as of Oct 12, 2026 is -383.91 %. In the previous year, Free Cash Flow to Debt Ratio was -2,467.95 % — a change of -84.44% (higher).

FCF/Debt

-383.91 %

YoY

-84.44%

Last updated:

Free Cash Flow to Debt Ratio of Lifeward is 2025 -383.91 % . Free Cash Flow to Debt Ratio of Lifeward was 2024 -2,467.95 % . It decreases by -84.44% higher compared to the previous year.

The Lifeward FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2018
-170.22 USD
Jan 1, 2019
-166.39 USD
Jan 1, 2020
-799.87 USD
Jan 1, 2021
-1,087.44 USD
Jan 1, 2022
-1,997.32 USD
Jan 1, 2023
-1,090.28 USD
Jan 1, 2024
-2,467.95 USD
Jan 1, 2025
-383.91 USD
The Lifeward FCF/Debt history
YEARFCF/DebtYoY
-383.91 %-84.44%
-2,467.95 %+126.36%
-1,090.28 %-45.41%
-1,997.32 %+83.67%
-1,087.44 %+35.95%
-799.87 %+380.72%
-166.39 %-2.25%
-170.22 %+16.04%
-146.68 %-5.60%
-155.38 %—
Access this data via the Eulerpool API

Lifeward Stock analysis

What does Lifeward do? Rewalk Robotics Ltd is a publicly traded company specializing in the development and manufacture of exoskeletons that enable individuals with spinal injuries or paralysis to regain mobility. It was founded in 2001 and is based in Marlborough, Massachusetts. The company's goal is to provide individuals with mobility impairments the opportunity for greater freedom of movement and improved quality of life. Rewalk Robotics has launched various products in the field of rehabilitation and industrial applications, and it continues to research and develop new applications for its technology. The exoskeletons use a combination of motors, sensors, and control systems to allow users to stand, walk, and even climb stairs. In addition to medical applications, Rewalk Robotics also provides exoskeletons for industrial use, enhancing worker safety and productivity. The company is actively involved in research and development to expand the therapeutic possibilities of exoskeletons for neurologic conditions such as stroke and Parkinson's disease. Rewalk Robotics is dedicated to innovation and technology, aiming to improve the lives of millions worldwide by providing greater mobility and autonomy. Lifeward is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lifeward stock

Free Cash Flow to Debt Ratio of Lifeward is -383.91 % in 2025.

Free Cash Flow to Debt Ratio of Lifeward changed from -2,467.95 % to -383.91 %, representing a -84.44% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Lifeward since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Lifeward with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Lifeward

All Key Metrics — Lifeward